Security key
75943R102
Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)
CUSIP: 75943R102
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 85,493,244
- Total 13F value
- $2,955,555,198
- Share change
- -2,208,318
- SEC-reported price per share
- $34.57
- Number of holders
- 135
- Value change
- -$171,240,328
- Number of buys
- 91
- Number of sells
- 32
- Shares outstanding
- 4,389,099
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
135
Top holders
10
RLAY full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2021
Previous quarter: Q4 2020
Relay Therapeutics, Inc. SEC filings
Relay Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75943R102
Recent filing periods:
Ownership snapshot
Top reported holders of RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SB INVESTMENT ADVISERS (U...
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F
Lead comparable stake: 636%
Showing 1-6 of 15 holder rows.
Quick read
SB INVESTMENT ADVISERS (UK) LTD leads the comparable SEC ownership view at 636%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SB INVESTMENT ADVISERS (UK) LTD's linked filing trail.
Comparable ownership
Top 5
SB INVESTMENT ADVISERS (UK) LTD
636%
TRV GP III, LLC
240%
FMR LLC
109%
Casdin Capital, LLC
87%
EcoR1 Capital, LLC
73%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
Company
|
636%
|
$1,159,730,000
27,904,963 shares
|
— | 31 Dec 2020 |
| TRV GP III, LLC |
13F
Company
|
240%
|
$438,504,000
10,551,115 shares
|
— | 31 Dec 2020 |
| FMR LLC |
13F
Company
|
109%
|
$197,918,000
4,762,238 shares
|
— | 31 Dec 2020 |
| Casdin Capital, LLC |
13F
Company
|
87%
|
$158,298,000
3,808,894 shares
|
— | 31 Dec 2020 |
| EcoR1 Capital, LLC |
13F
Company
|
73%
|
$133,019,000
3,200,649 shares
|
— | 31 Dec 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
72%
|
$131,203,000
3,156,974 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
135
Shares
85,493,244
Rows available
135
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
115
Q1 2021 holders
135
Holder diff
20
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend